Literature DB >> 30414893

Negative regulation of angiogenesis by novel micro RNAs.

Veronica Sanchez1, Flora Golyardi1, Dominique Mayaki1, Raquel Echavarria1, Sharon Harel1, Janguo Xia2, Sabah N A Hussain3.   

Abstract

Angiopoietin-1 (Ang-1) is a ligand of Tie-2 receptors that promotes survival, migration, and differentiation of endothelial cells (ECs). Recent studies have identified several microRNA (miRNA) families that either promote or inhibit angiogenesis. To date, the nature and functional importance of miRNAs in Ang-1-induced angiogenesis are unknown. Microarray screening of known miRNAs in human umbilical vein endothelial cells (HUVECs) revealed that the expressions of miR-103b, miR-330-5p, miR-557, miR-575, miR-1287-5p, and miR-1468-5p significantly decrease following exposure to Ang-1 for 24 h. Exposure to the angiogenesis factors angiopoietin-2 (Ang-2), vascular endothelial growth factor, fibroblast growth factor 2, and transforming growth factor β also inhibits miR-103b expression, but exerts varying effects on the other miRNAs. By overexpressing miR-103b, miR-330-5p, miR-557, miR-575, miR-1287-5p, and miR-1468-5p with selective mimics, we demonstrated that the pro-survival effects of Ang-1 are eliminated, Caspase-3 activity increases, and cell migration, proliferation, and capillary-like tube formation decreases. Conversely, transfection with selective miRNA inhibitors increases cell survival, inhibits Caspase-3 activity, and stimulates migration, proliferation and tube formation. miRNet miRNA-target gene network analyses revealed that miR-103, miR-330-5p, miR-557, miR-575, miR-1287-5p, and miR-1468-5p directly interact with 47, 95, 165, 108, 49, and 16 gene targets, respectively. Since many of these genes are positive regulators of angiogenic processes, we conclude that these miRNAs function as anti-angiogenic miRNAs and that their downregulation may be essential for Ang-1-induced angiogenesis to occur.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Angiopoietins; Cell differentiation; Cell migration; Cell proliferation; Endothelial cells; microRNAs

Mesh:

Substances:

Year:  2018        PMID: 30414893     DOI: 10.1016/j.phrs.2018.11.010

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  7 in total

Review 1.  Current perspectives on the dysregulated microRNAs in gastric cancer.

Authors:  Shirin Azarbarzin; Reza Safaralizadeh; Mahdi Banan Khojasteh; Amir Baghbanzadeh; Behzad Baradaran
Journal:  Mol Biol Rep       Date:  2020-08-09       Impact factor: 2.316

2.  Comparison of the Therapeutic Effect of Allogeneic and Xenogeneic Small Extracellular Vesicles in Soft Tissue Repair.

Authors:  Jia Dong; Yue Wu; Yan Zhang; Mei Yu; Weidong Tian
Journal:  Int J Nanomedicine       Date:  2020-09-22

3.  The role and mechanism of miR-557 in inhibiting the differentiation and maturation of megakaryocytes in immune thrombocytopenia.

Authors:  Yan Wang; Yujie Guo; Xiaolei Zhang; Hui Zhao; Bingbing Zhang; Yi Wu; Jingyu Zhang
Journal:  RNA Biol       Date:  2021-02-15       Impact factor: 4.652

4.  Roles of miR-640 and Zinc Finger Protein 91 (ZFP91) in Angiopoietin-1-Induced In Vitro Angiogenesis.

Authors:  Sharon Harel; Veronica Sanchez-Gonzalez; Raquel Echavarria; Dominique Mayaki; Sabah Na Hussain
Journal:  Cells       Date:  2020-07-02       Impact factor: 6.600

5.  miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib.

Authors:  Leisheng Wang; He En; Lei Yang; Yanbing Zhang; Baisheng Sun; Jianjiang Gao
Journal:  Onco Targets Ther       Date:  2019-08-21       Impact factor: 4.147

6.  Angiogenic Potential of VEGF Mimetic Peptides for the Biofunctionalization of Collagen/Hydroxyapatite Composites.

Authors:  Suya Wang; Felix Umrath; Wanjing Cen; Siegmar Reinert; Dorothea Alexander
Journal:  Biomolecules       Date:  2021-10-19

7.  microRNA Sequencing of CD34+ Sorted Adipose Stem Cells Undergoing Endotheliogenesis.

Authors:  Shahensha Shaik; Elizabeth Martin; Daniel Hayes; Jeffrey Gimble; Ram Devireddy
Journal:  Stem Cells Dev       Date:  2021-02-08       Impact factor: 3.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.